Table 2.
Baseline characteristics of individuals participating in the present study on ocular complications as compared with the non-participants from the original Diabetes Prevention Study (DPS) study population.
| Variable | Participants, N = 211 | No Participants, N = 311 | p-Value |
|---|---|---|---|
| Age, years | 53.8 ± 7.0 | 56.1 ± 7.1 | <0.001 |
| Body weight, kg | 86.7 ± 14.6 | 85.8 ± 13.9 | 0.470 |
| Fasting plasma glucose, mmol/L | 5.9 ± 0.8 | 6.3 ± 0.7 | <0.001 |
| 2 h plasma glucose, mmol/L | 8.8 ± 1.4 | 9.0 ± 1.5 | 0.254 |
| Fasting insulin, mU/L | 14.4 ± 7.4 | 15.1 ± 7.5 | 0.332 |
| Systolic blood pressure, mmHg | 138.1 ± 18.8 | 138.0 ± 16.9 | 0.968 |
| Diastolic blood pressure, mmHg | 85.7 ± 9.6 | 85.7 ± 9.8 | 0.985 |
| Serum total cholesterol, mmol/L | 5.6 ± 1.0 | 5.6 ± 0.9 | 0.642 |
| High-density lipoprotein cholesterol, mmol/L | 1.2 ± 0.3 | 1.2 ± 0.3 | 0.553 |
| Serum triglycerides, mmol/L | 1.7 ± 0.7 | 1.7 ± 0.8 | 0.716 |